期刊文献+

卵巢癌基因治疗的新进展 被引量:4

New advancement in gene therapy for ovarian cancer
下载PDF
导出
摘要 卵巢癌是恶性度最高的妇科肿瘤之一 ,由于手术和化疗的不尽人意 ,基因治疗是当今肿瘤研究的热点。卵巢癌的基因治疗载体主要分为病毒载体系统和非病毒载体系统。其中 ,腺病毒载体转染效率较高 ,是目前基因治疗的主要手段和最有前途的载体。卵巢癌的基因治疗策略有分子化学治疗 ,基因替代和免疫系统的基因调控。由于这一领域的迅速发展 。 Ovarian cancer is one of the most malignant tumors in women. Gene therapy is the hot spot in tumor research because of the low efficiency of the operation and chemical therapy. The application of gene therapy strategies for ovarian cancer has employed various viral and nonviral vectors. Thus far, adenovirus has been the most promising vehicle for its high efficiency. Current strategies in gene therapy for ovarian cancer involved molecular chemical therapy, gene replacement and gene control of the immune system. Advances in the field are occurring rapidly and this strategy does appear promising for the treatment of ovarian cancer.
作者 黄元英
机构地区 天津市南开医院
出处 《天津药学》 2004年第2期53-56,共4页 Tianjin Pharmacy
关键词 基因治疗 卵巢癌 载体 gene therapy, ovarian cancer, vector
  • 相关文献

参考文献27

  • 1李叶,张毅,李红霞,唐蔚清,闫春华,黎健.外源性Rb基因对卵巢癌细胞株生长的抑制作用[J].中华妇产科杂志,2000,35(2):98-100. 被引量:5
  • 2Cemazar M, Sersa G, Wilson J, et al. Effective gene transfer to solid tumors using different nonviral gene delivery techniques:electroporation, liposomes, and integrin-targeted vector. Cancer Gene Ther, 2002, 9(4):399
  • 3Al-Hendy A, Magliocco A M, Al-Tweigeri T, et al. Ovarian cancer gene therapy: repeated treatment with thymidine kinase in an adenovirus vector and ganciclovir improves survival in a novel immunocompetent murine model. Am J Obstet Gynecol, 2000 Mar,182(3):
  • 4Burke F, East N, Upton C, et al. interfer on gamma induces cell cycle arrest and apoptosis in a mode if ovarian cancer: enhance ment of effect by batimastat. Eur-J-Cancer, 1997,33(7):1114
  • 5Kigawa J, Terakawa N. Adenovirus-mediated transfer of a p53gene in ovarian cancer. Adv Exp Med Biol. 2000,465:207
  • 6Song K, Cowan K H, Sinha B K. In vivo studies of adenovirus-mediated p53 gene therapy for cis-platinum-resistant human ovarian tumor xenografts. Oncol Res. 1999,11(3):153
  • 7Arap W,Nishikawa R,Furnari F B, et al. Replacement of the P16/CDKN2 gene suppresses human glioma cell growth. Cancer Res,1995,55(6):1351
  • 8Minaguchi T, Mori T, Kanamori Y, et al. Growth suppression of human ovarian cancer cells by adenovirus mediated transfer of the PTEN gene. Cancer Res,1999,59(24):6063
  • 9Waston J M,Berek J S, Maza O M. Growth inhibition of ovarian cells induced by antisense IL-6 oligonucleotides . Gynecol Oncol,1993,49:8
  • 10Kramm C M, Niehues T, Rainov N G. Experimental strategies for combined suicide and immune cancer gene therapy. An overview.Methods Mol Biol, 2003,215:137

二级参考文献54

  • 1翁进,朱雪静,林勇,汪钟.甘糖酯对血小板与内皮细胞功能的影响[J].中国医学科学院学报,1997,19(6):414-418. 被引量:10
  • 2陈波洁.P53基因在卵巢癌中的研究进展[J].国外医学(妇产科学分册),1996,23(4):208-210. 被引量:2
  • 3翁进 朱雪静.苷糖酯对血小板与内皮细胞功能的影响[J].中国医学科学院学报,1997,19:414-417.
  • 4沈羽非 方福德.真核基因表达调控(第2版)[M].北京:高等教育出版社,1996.145-146,164-165.
  • 5[1]Crawford R. Gynecologic oncology:current diagnosis and treatment. London: WB Saunders, 1996. 203~212.
  • 6[2]Santin AD, Ioli GR, Hiserodt JC, et al. Development and characterization of an IL - 4 - secreting human ovarian carcinoma cell line. Gynecol Oncol, 1995,58: 230.
  • 7[3]Santin AD, Ioli GR, Hiserodt JC, et al. Development and characterization of an interleukin - 2 - transduced human ovarian carcinoma tumor vaccine not expressing major histocompatibility complex molecules. Am J Obstet Gynecol, 1996,174 (2), 633.
  • 8[4]D' Incan C, Sanches R, Kuiper M, et al. Gamma - interferon gene transfer as a therapeutic strategy for ovarian cancer. Adv Exp Med Biol, 1998,451: 349.
  • 9[5]Nakamura Y, Wakimoto H, Abe J, et al. Adoptive immunotherapy with murine tumor- specific T lymphocytes engineered to secret interleukin 2. Cancer Res, 1994,54: 5757.
  • 10[6]Itoh Y, Koshita Y, Takahashi M, et al. Characterizaton of tumor-necrosis - factor - gene - transduced tumor - infiltrating lymphocytes from ascitic fluid of cancer patients: analysis of cytolytic activity, growth rate,adhesion molecule expression and cytokine production. Cancer Immuno Immunother, 1995,40: 95.

共引文献9

同被引文献22

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部